These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26573828)

  • 1. Dose impact of rectal gas on prostatic IMRT and VMAT.
    Sasaki M; Ikushima H; Tominaga M; Kamomae T; Kishi T; Oita M; Harada M
    Jpn J Radiol; 2015 Dec; 33(12):723-33. PubMed ID: 26573828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of geometrical uncertainties on localized prostate radiotherapy of patients with bilateral metallic hip prostheses using 3D-CRT, IMRT and VMAT: A planning study.
    Soda R; Hatanaka S; Hariu M; Shimbo M; Yamano T; Nishimura K; Kondo S; Utsumi N; Takahashi T
    J Xray Sci Technol; 2020; 28(2):243-254. PubMed ID: 31985486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Volumetric modulated arc therapy: planning and evaluation for prostate cancer cases.
    Zhang P; Happersett L; Hunt M; Jackson A; Zelefsky M; Mageras G
    Int J Radiat Oncol Biol Phys; 2010 Apr; 76(5):1456-62. PubMed ID: 19540062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
    Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VMAT vs. 7-field-IMRT: assessing the dosimetric parameters of prostate cancer treatment with a 292-patient sample.
    Kopp RW; Duff M; Catalfamo F; Shah D; Rajecki M; Ahmad K
    Med Dosim; 2011; 36(4):365-72. PubMed ID: 21377863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimising the dosimetric quality and efficiency of post-prostatectomy radiotherapy: a planning study comparing the performance of volumetric-modulated arc therapy (VMAT) with an optimised seven-field intensity-modulated radiotherapy (IMRT) technique.
    Nguyen BT; Hornby C; Kron T; Cramb J; Rolfo A; Pham D; Haworth A; Tai KH; Foroudi F
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):211-9. PubMed ID: 22498196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.
    Ost P; Speleers B; De Meerleer G; De Neve W; Fonteyne V; Villeirs G; De Gersem W
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):920-6. PubMed ID: 20675077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the role of volumetric modulated arc therapy (VMAT) relative to IMRT and helical tomotherapy in the management of localized, locally advanced, and post-operative prostate cancer.
    Davidson MT; Blake SJ; Batchelar DL; Cheung P; Mah K
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1550-8. PubMed ID: 21543164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
    Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
    Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose comparisons for conformal, IMRT and VMAT prostate plans.
    Sale C; Moloney P
    J Med Imaging Radiat Oncol; 2011 Dec; 55(6):611-21. PubMed ID: 22141609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosimetric and efficiency comparison of high-dose radiotherapy for esophageal cancer: volumetric modulated arc therapy versus fixed-field intensity-modulated radiotherapy.
    Lin CY; Huang WY; Jen YM; Chen CM; Su YF; Chao HL; Lin CS
    Dis Esophagus; 2014 Aug; 27(6):585-90. PubMed ID: 24134466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A treatment planning and acute toxicity comparison of two pelvic nodal volume delineation techniques and delivery comparison of intensity-modulated radiotherapy versus volumetric modulated arc therapy for hypofractionated high-risk prostate cancer radiotherapy.
    Myrehaug S; Chan G; Craig T; Weinberg V; Cheng C; Roach M; Cheung P; Sahgal A
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e657-62. PubMed ID: 22245189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistently better treatment planning results of intensity-modulated (IMRT) over conformal radiotherapy (3D-CRT) in prostate cancer patients with significant variation of clinical target volume and/or organs-at-risk.
    Fenoglietto P; Laliberte B; Allaw A; Ailleres N; Idri K; Hay MH; Moscardo CL; Gourgou S; Dubois JB; Azria D
    Radiother Oncol; 2008 Jul; 88(1):77-87. PubMed ID: 18215434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
    Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
    Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of testicular dose delivered by intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) in patients with prostate cancer.
    Martin JM; Handorf EA; Price RA; Cherian G; Buyyounouski MK; Chen DY; Kutikov A; Johnson ME; Ma CM; Horwitz EM
    Med Dosim; 2015; 40(3):186-9. PubMed ID: 25595491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy.
    Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
    Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
    Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of treatment plans and accuracy of in vivo portal dosimetry in hybrid intensity-modulated radiation therapy and volumetric modulated arc therapy for prostate cancer.
    Bedford JL; Smyth G; Hanson IM; Tree AC; Dearnaley DP; Hansen VN
    Radiother Oncol; 2016 Aug; 120(2):320-6. PubMed ID: 27470308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer planning: Complex conformal vs modulated therapies.
    Chapman KL; Witek ME; Chen H; Showalter TN; Bar-Ad V; Harrison AS
    Med Dosim; 2016; 41(2):100-4. PubMed ID: 26831922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Online adaptation and verification of VMAT.
    Crijns W; Defraene G; Van Herck H; Depuydt T; Haustermans K; Maes F; Van den Heuvel F
    Med Phys; 2015 Jul; 42(7):3877-91. PubMed ID: 26133589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.